Evidence for the elevation of serum carcinoembryonic antigen and tumor associated glycoprotein-72 levels in patients administered interferons

Sera were collected from 111 patients diagnosed with adenocarcinoma or nonadenocarcinoma malignancies who received different schedules of interferon (IFN)-gamma or IFN-beta ser alone or in combination. Serum carcinoembryonic antigen (CEA) and tumor-associated glycoprotein-72 (TAG-72) antigen levels...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 1991-08, Vol.51 (16), p.4155-4163
Hauptverfasser:	GREINER, J. W, GUADAGNI, F, GOLDSTEIN, D, BORDEN, E. C, RITTS, R. E, WITT, P, LOBUGLIO, A. F, SALEH, M. N, SCHLOM, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood Adenocarcinoma - immunology Adenocarcinoma - therapy Antigens, Neoplasm - analysis Antineoplastic agents Biological and medical sciences Biomarkers, Tumor - blood Carcinoembryonic Antigen - analysis Female Glycoproteins - analysis Humans Immunotherapy Interferon Type I - therapeutic use Interferon-gamma - therapeutic use Medical sciences Neoplasms - blood Neoplasms - immunology Neoplasms - therapy Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!